SZShusen Zhang

Shusen Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shusen Zhang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Duoxi Duan

    Chengdu University of Traditional Chinese Medicine, 37 Shi'er Qiao Road, Jinniu District, Chengdu, Sichuan, 610075, People's Republic of China

    1 shared publication
  • Hui Zheng

    Chengdu University of Traditional Chinese Medicine, 37 Shi'er Qiao Road, Jinniu District, Chengdu, Sichuan, 610075, People's Republic of China

    1 shared publication
  • Ling Zhao

    Acupuncture and Tuina School Chengdu University of Traditional Chinese Medicine Chengdu Sichuan China

    1 shared publication
  • Lingyun Lu

    Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Ning Li

    Department of Integrated Traditional Chinese and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China

    1 shared publication
  • Qianhua Zheng

    School of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China

    1 shared publication

Latest Publications

  • Open Access

    The long-term effect of acupuncture for patients with chronic tension-type headache: study protocol for a randomized controlled trial

    by Lingyun Lu, Hui Zheng, Qianhua Zheng, Xinyu Hao, Siyuan Zhou, Shusen Zhang, Tao Wei, Tao Gao, Duoxi Duan, Ling Zhao, et al.

    The effectiveness of acupuncture for patients with chronic tension-type headache (CTTH) is controversial. In this article, we report the protocol for a randomized controlled trial aiming to evaluate the long-term effect of acupuncture for CTTH, in comparison with superficial acupuncture. A two-armed, parallel-design, patient-assessor blind, randomized controlled trial is underway in China. A total of 218 participants with CTTH will be randomly assigned to the treatment group or the control group in a 1:1 ratio. Participants in the treatment group and control group will receive acupuncture or superficial acupuncture treatments in a fixed prescription of acupoints respectively, for a total of 20 sessions over 8 weeks. The posttreatment follow-up period will be 24 weeks. The primary outcome will be the proportion of responders assessed at week 16 after randomization. The secondary outcomes will include the number of headache days, the mean intensity of headache, the reduction of medication intake, results from the 36-item short form health survey, the Hamilton Depression Scale and the Hamilton Anxiety Scale, the number of participants with adverse events, the expectation value of acupuncture treatment, and the intensity of deqi sensation. The first five secondary outcomes will be assessed or calculated at baseline, and at 4, 8, 12, 16, 20, 24, 28, and 32 weeks after randomization. Moreover, the expectation value will be collected at baseline and at week 8 after randomization, the intensity of deqi sensation will be assessed at 5 minutes after each treatment and adverse events will be summarized at the end of the follow-up period. Results from this trial will provide evidence for the long-term effect of acupuncture for CTTH with a long follow-up period. ClinicalTrial.gov NCT03133884 . Registered on 25 April 2017.